![Sophia Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Sophia Park currently works at MyoKardia, Inc., as Vice President from 2020, Mirati Therapeutics, Inc., as Vice President from 2024, Rayzebio, Inc., as Vice President from 2024, and Karuna Therapeutics, Inc., as Vice President from 2024.
Posizioni attive di Sophia Park
| Società | Posizione | Inizio |
|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | 17/11/2020 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| RAYZEBIO, INC. | Corporate Officer/Principal | 26/02/2024 |
| KARA THER | Corporate Officer/Principal | 18/03/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
